Skip to Content
Merck
CN

SRP6304

Chylomicrons from human plasma

≥95% (SDS-PAGE)

Synonym(s):

AD2, LDLCQ5, LPG, MGC1571

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

NACRES:
NA.32
UNSPSC Code:
12352202
Biological source:
human
Assay:
≥95% (SDS-PAGE)
Form:
liquid
Mol wt:
50-1,000 kDa
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


biological source

human

assay

≥95% (SDS-PAGE)

form

liquid

mol wt

50-1,000 kDa

packaging

pkg of 1 mg

shipped in

wet ice

storage temp.

2-8°C

General description

Chylomicrons are large triglyceride-rich lipoproteins and one of the major lipoprotein particles in plasma. It contains a central lipid core composed of triglycerides, esterified cholesterol, and phospholipids.

Application

Chylomicrons from human plasma has been used as a standard for the identification and chemical characterization of lipoproteins in plasma and platelet samples by Raman spectra.

Biochem/physiol Actions

Chylomicrons are synthesized from dietary lipids like fatty acids and cholesterol inside enterocytes. Circulation of chylomicrons distributes dietary triglyceride to adipose tissue and muscle. Elevated chylomicron levels are observed in the blood of familial chylomicronemia syndrome patients.

Physical form

In 150 mM NaCl, pH 7.4, and 0.01% EDTA.


Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

高风险级别生物产品--人源产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Agustin Enciso-Martinez et al.
Journal of extracellular vesicles, 9(1), 1730134-1730134 (2020-03-12)
Extracellular vesicles (EVs) present in blood originate from cells of different origins such as red blood cells (RBCs), platelets and leukocytes. In patients with cancer, a small portion of EVs originate from tumour cells and their load is associated with
Chylomicron
Rahmany S and Jialal I
Biochemistry (2021)



Global Trade Item Number

SKUGTIN
SRP6304-1MG04061837251672